Acetic Acid

Acetic Acid

SCHEMBL11280978

CC(=O)O.CC(=O)O.CN

nearest known ligand 0.78

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR3 O14843 2/20 0.78
LCK P06239 1/20 0.78
FYN P06241 1/20 0.78
LMNA P02545 3/20 0.55
ALOX15 P16050 1/20 0.55
BLM P54132 1/20 0.55
PMP22 Q01453 1/20 0.55
TSHR P16473 2/20 0.46
ACHE P22303 1/20 0.46
THPO P40225 1/20 0.46
CA1 P00915 3/20 0.42
TDP1 Q9NUW8 3/20 0.40
CA2 P00918 2/20 0.40
CA9 Q16790 1/20 0.40
LDHA P00338 1/20 0.39
LDHB P07195 1/20 0.39
ALDH1A1 P00352 4/20 0.36
OR51E2 Q9H255 2/20 0.36
GLRA1 P23415 1/20 0.36
SLC6A9 P48067 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetic Acid SCHEMBL895797 1.00
Acetic Acid SCHEMBL7897388 1.00 FFAR3 (0.78) FFAR3LCKFYNLMNAALOX15
Acetic Acid SCHEMBL8583737 0.95
Acetic Acid SCHEMBL28979634 0.95 FFAR3 (0.70) FFAR3LCKFYNLMNAALOX15
Acetic Acid SCHEMBL6186402 0.95
Acetic Acid SCHEMBL29189199 0.95
Acetic Acid SCHEMBL11454405 0.95
Acetic Acid SCHEMBL11523446 0.95
Acetic Acid SCHEMBL7760788 0.95 FFAR3 (0.70) FFAR3LCKFYNLMNAALOX15
Acetic Acid SCHEMBL28248105 0.95

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-3987140-A SPINNING WITH BORIC ACID OR A BORATE KURARAY CO., LTD. (JA) 1976-10-19 US claimed
US-20250122146-A1 COMPOUNDS FOR REDUCING NEUROINFLAMMATION THE SCRIPPS RESEARCH INSTITUTE 2025-04-17 US disclosed
WO-2023055733-A1 COMPOUNDS FOR REDUCING NEUROINFLAMMATION THE SCRIPPS RESEARCH INSTITUTE (US) 2023-04-06 WO disclosed
US-10766874-B2 Manufacturing process for triazine, pyrimidine and pyridine derivatives UNIVERSITAET BASEL (CH) 2020-09-08 US disclosed
US-20190016698-A1 NOVEL MANUFACTURING PROCESS FOR TRIAZINE, PYRIMIDINE AND PYRIDINE DERIVATIVES TORQUR AG (CH) 2019-01-17 US disclosed
EP-3134388-B1 NOVEL MANUFACTURING PROCESS FOR TRIAZINE, PYRIMIDINE AND PYRIDINE DERIVATIVES UNIV BASEL (CH) 2019-01-09 EP disclosed
US-10100031-B2 Manufacturing process for triazine, pyrimidine and pyridine derivatives UNIVERSITAET BASEL (CH) 2018-10-16 US disclosed
EP-3134388-A1 NOVEL MANUFACTURING PROCESS FOR TRIAZINE, PYRIMIDINE AND PYRIDINE DERIVATIVES Universität Basel (CH) 2017-03-01 EP disclosed
US-20170037027-A1 NOVEL MANUFACTURING PROCESS FOR TRIAZINE, PYRIMIDINE AND PYRIDINE DERIVATIVES TORQUR AG (CH) 2017-02-09 US disclosed
WO-2015162084-A1 NOVEL MANUFACTURING PROCESS FOR TRIAZINE, PYRIMIDINE AND PYRIDINE DERIVATIVES UNIVERSITAET BASEL (CH) 2015-10-29 WO disclosed
US-4355141-A NITROGEN-COMPOUND CONTAINING RESOLE RESIN PREVENTS STICKING MITSUI TOATSU CHEMICAL, INC. (JP) 1982-10-19 US disclosed
US-3987140-A SPINNING WITH BORIC ACID OR A BORATE KURARAY CO., LTD. (JA) 1976-10-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190016698-A1 NOVEL MANUFACTURING PROCESS FOR TRIAZINE, PYRIMIDINE AND PYRIDINE DERIVATIVES IL5, WIZ, TPMT FFAR3 2134/4885LCK 3198/4885FYN 3213/4885
US-10100031-B2 Manufacturing process for triazine, pyrimidine and pyridine derivatives IL5, WIZ, TPMT FFAR3 2226/4885LCK 3273/4885FYN 3123/4885
US-20250122146-A1 COMPOUNDS FOR REDUCING NEUROINFLAMMATION HSF1, HSPA2, KEAP1 FFAR3 3091/4885LCK 1192/4885FYN 85/4885
US-20170037027-A1 NOVEL MANUFACTURING PROCESS FOR TRIAZINE, PYRIMIDINE AND PYRIDINE DERIVATIVES IL5, WIZ, TPMT FFAR3 2286/4885LCK 3272/4885FYN 3201/4885
US-10766874-B2 Manufacturing process for triazine, pyrimidine and pyridine derivatives IL5, WIZ, TPMT FFAR3 2072/4885LCK 3053/4885FYN 2805/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.